RIZZI LAURA

Meanti, R., Criscione, M., Sartori, E., Rizzi, L., Bresciani, E., Mauri, M., et al. (2026). Anti-Inflammatory Effects of Progesterone on Human Microglia via TLR4/NLRP3 Pathway Modulation: Relevance to Drug-Resistant Epilepsy. PHARMACEUTICALS, 19(6) [10.3390/ph19060920]. Dettaglio

Meanti, R., Bresciani, E., Rizzi, L., Molteni, L., Coco, S., Omeljaniuk, R., et al. (2025). Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases. BIOMÉDECINE & PHARMACOTHÉRAPIE, 186(May 2025) [10.1016/j.biopha.2025.118044]. Dettaglio

Bracchi, M., Rizzi, L., Russo, L. (2025). Extracellular matrix (ECM) and cellular features of a pediatric meniscus. Intervento presentato a: Pediatric meniscal injuries - TRANSALPINE CENTER OF PEDIATRIC SPORTS MEDICINE AND SURGERY 5TH CONFERENCE 07 febbraio 2025, Centro Congressi – IRCCS San Gerardo dei Tintori, Monza, Italy. Dettaglio

Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Molteni, L., Omeljaniuk, R., et al. (2024). Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study. Intervento presentato a: 9th European Congress of Pharmacology (EPHAR 2024), Atene, Grecia. Dettaglio

Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Sartori, E., Omeljaniuk, R., et al. (2024). Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study. Intervento presentato a: 42° Congresso Nazionale SIF. Science today for a better medicine tomorrow, Sorrento, Italia. Dettaglio